Pacific Biosciences Of California (PACB) Change in Account Payables (2010 - 2026)

Pacific Biosciences Of California's Change in Account Payables history runs 17 years deep, the most recent figure standing at -$4.3 million for Q1 2026.

• On a quarterly basis, Change in Account Payables fell 183.41% year-over-year to -$4.3 million in Q1 2026; TTM through Mar 2026 was -$315000.0, a 95.34% increase from a year earlier, with the FY2025 full-year figure at $2.5 million, up 76.65% from the prior year.
• Change in Account Payables retreated to -$4.3 million in Q1 2026 per PACB's latest filing, from $1.7 million in the prior quarter.
• Across five years, Change in Account Payables topped out at $6.6 million in Q1 2024 and bottomed at -$5.6 million in Q3 2024.
• The 5-year median for Change in Account Payables is -$486000.0 (2022), against an average of $46823.5.
• Across the five-year window, Change in Account Payables surged 4065.36% in 2022 and plunged 1520.0% in 2023, its largest moves.
• Year by year, Change in Account Payables stood at -$486000.0 in 2022, then plunged by 208.64% to -$1.5 million in 2023, then jumped by 341.8% to $3.6 million in 2024, then slumped by 52.55% to $1.7 million in 2025, then tumbled by 351.13% to -$4.3 million in 2026.
• Per Business Quant, the three latest PACB Change in Account Payables figures stand at -$4.3 million (Q1 2026), $1.7 million (Q4 2025), and $1.3 million (Q3 2025).